Published in N Engl J Med on January 24, 2013
Screening and Multiple Intervention on Lung Epidemics (SMILE) | NCT03654105
A Study of Unfiltered Cigarettes Among Committed Smokers | NCT03749876
E-cigarettes: a scientific review. Circulation (2014) 7.99
An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med (2015) 4.18
Combination treatment with varenicline and bupropion in an adaptive smoking cessation paradigm. Am J Psychiatry (2014) 2.90
New evidence that cigarette smoking remains the most important health hazard. N Engl J Med (2013) 2.84
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
US lung cancer trends by histologic type. Cancer (2014) 2.46
Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis. Gut (2015) 2.19
Lung Cancer Risk and Demographic Characteristics of Current 20-29 Pack-year Smokers: Implications for Screening. J Natl Cancer Inst (2015) 2.09
Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies. Lancet (2015) 1.83
Smoking, sex, risk factors and abdominal aortic aneurysms: a prospective study of 18 782 persons aged above 65 years in the Southern Community Cohort Study. J Epidemiol Community Health (2015) 1.46
Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA (2014) 1.45
Complying with the framework convention for tobacco control: an application of the Abridged SimSmoke model to Israel. Isr J Health Policy Res (2016) 1.38
Burden of total and cause-specific mortality related to tobacco smoking among adults aged ≥ 45 years in Asia: a pooled analysis of 21 cohorts. PLoS Med (2014) 1.27
Smoking cessation in smokers who smoke menthol and non-menthol cigarettes. Addiction (2014) 1.18
Electronic cigarettes. Cardiology patient page. Circulation (2014) 1.18
Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India (2013) 1.13
Smoking-related mortality in the United States. N Engl J Med (2013) 1.12
Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis (2014) 1.11
Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res (2015) 1.11
Tobacco Product Waste: An Environmental Approach to Reduce Tobacco Consumption. Curr Environ Health Rep (2014) 1.10
Tobacco smoking and all-cause mortality in a large Australian cohort study: findings from a mature epidemic with current low smoking prevalence. BMC Med (2015) 1.09
Mutagenesis. Smoking is associated with mosaic loss of chromosome Y. Science (2014) 1.08
Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses. JAMA Oncol (2016) 1.08
The hazards of death by smoking in middle-aged women. Eur J Epidemiol (2013) 1.08
Emerging tobacco-related cancer risks in China: A nationwide, prospective study of 0.5 million adults. Cancer (2015) 1.07
Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials. J Clin Oncol (2017) 1.00
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics. J Thorac Oncol (2016) 0.99
Alcohol, tobacco, and drug use among emergency department patients. Drug Alcohol Depend (2014) 0.98
Smoking and diabetes: does the increased risk ever go away? Am J Epidemiol (2013) 0.98
Agonistic induction of PPARγ reverses cigarette smoke-induced emphysema. J Clin Invest (2014) 0.97
Epidemiology and aetiology of heart failure. Nat Rev Cardiol (2016) 0.93
The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models. Clin Sci (Lond) (2014) 0.93
Years of life lost as a measure of cancer burden on a national level. Br J Cancer (2014) 0.91
Systematic and meta-analytic review of research examining the impact of menstrual cycle phase and ovarian hormones on smoking and cessation. Nicotine Tob Res (2015) 0.90
Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90
Changes in smoking for adults with and without alcohol and drug use disorders: longitudinal evaluation in the US population. Am J Drug Alcohol Abuse (2013) 0.89
Human immunodeficiency virus-associated obstructive lung diseases. Clin Chest Med (2013) 0.89
Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States. Front Oncol (2015) 0.89
Lung cancer mortality and years of potential life lost among males and females over six decades in a country with high smoking prevalence: an observational study. BMC Cancer (2015) 0.88
Changing rates for liver and lung cancers in Qidong, China. Chem Res Toxicol (2013) 0.87
Women and lung cancer: what is new? Semin Thorac Cardiovasc Surg (2013) 0.87
The changing public image of smoking in the United States: 1964-2014. Cancer Epidemiol Biomarkers Prev (2014) 0.87
Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. J Clin Oncol (2016) 0.86
Smoking and cardiac rehabilitation participation: Associations with referral, attendance and adherence. Prev Med (2015) 0.86
CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis. J Natl Cancer Inst (2015) 0.86
Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk. JAMA Cardiol (2017) 0.86
Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling. Am J Physiol Heart Circ Physiol (2013) 0.85
Smoking-related mortality in the United States. N Engl J Med (2013) 0.85
Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis. PLoS One (2013) 0.84
Effect of a mobile phone intervention on quitting smoking in a young adult population of smokers: randomized controlled trial study protocol. JMIR Res Protoc (2015) 0.84
Smoking habits and nicotine dependence of North Korean male defectors. Korean J Intern Med (2016) 0.84
Outcomes of a Tailored Intervention for Cigarette Smoking Cessation Among Latinos Living With HIV/AIDS. Nicotine Tob Res (2015) 0.83
Knowledge about health effects of cigarette smoking and quitting among Italian university students: the importance of teaching nicotine dependence and treatment in the medical curriculum. Biomed Res Int (2014) 0.83
The 21st century benefits of smoking cessation in Europe. Eur J Epidemiol (2013) 0.83
Impact of Cigarette Smoking and Smoking Cessation on Life Expectancy Among People With HIV: A US-Based Modeling Study. J Infect Dis (2016) 0.82
Abnormal sympathetic nerve activity in women exposed to cigarette smoke: a potential mechanism to explain increased cardiac risk. Am J Physiol Heart Circ Physiol (2013) 0.82
Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. J Transl Med (2015) 0.82
Fructose-containing sugars and cardiovascular disease. Adv Nutr (2015) 0.82
Correlation of an epigenetic mitotic clock with cancer risk. Genome Biol (2016) 0.82
Genetic variation (CHRNA5), medication (combination nicotine replacement therapy vs. varenicline), and smoking cessation. Drug Alcohol Depend (2015) 0.82
Nuclear and mitochondrial DNA alterations in newborns with prenatal exposure to cigarette smoke. Int J Environ Res Public Health (2015) 0.81
Duplicated copy of CHRNA7 increases risk and worsens prognosis of COPD and lung cancer. Eur J Hum Genet (2014) 0.81
Should Never-Smokers at Increased Risk for Lung Cancer Be Screened? J Thorac Oncol (2015) 0.81
Understanding Tobacco Use Onset Among African Americans. Nicotine Tob Res (2016) 0.80
COPD and its association with smoking in the Mainland China: a cross-sectional analysis of 0.5 million men and women from ten diverse areas. Int J Chron Obstruct Pulmon Dis (2015) 0.80
An evaluation study of a gender-specific smoking cessation program to help Hong Kong Chinese women quit smoking. BMC Public Health (2015) 0.80
Smokescreen: a targeted genotyping array for addiction research. BMC Genomics (2016) 0.80
Trends in smoking prevalence and attributable mortality in China, 1991-2011. Prev Med (2016) 0.79
Smoking behavior and lung cancer in a biracial cohort: the Atherosclerosis Risk in Communities study. Am J Prev Med (2014) 0.79
Interplay of genetic risk (CHRNA5) and environmental risk (partner smoking) on cigarette smoking reduction. Drug Alcohol Depend (2014) 0.79
Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis. J Neurol Neurosurg Psychiatry (2015) 0.78
Sex/gender differences in smoking cessation: A review. Prev Med (2016) 0.78
Association between positivity and smoking cessation. Biomed Res Int (2014) 0.78
A Cross-sectional Examination of What Smokers Perceive to be Important and Their Willingness to Pay for Tobacco Cessation Medications. J Public Health Manag Pract (2015) 0.78
Application of the Abridged SimSmoke model to four Eastern Mediterranean countries. Tob Control (2015) 0.78
Small angle x-ray scattering with edge-illumination. Sci Rep (2016) 0.78
Gender differences in self-reported withdrawal symptoms and reducing or quitting smoking three years later: A prospective, longitudinal examination of U.S. adults. Drug Alcohol Depend (2016) 0.78
Sex differences of COPD phenotypes in nonsmoking patients. Int J Chron Obstruct Pulmon Dis (2016) 0.77
Cancer incidence and survival trends by subtype using data from the Surveillance Epidemiology and End Results Program, 1992-2013. Cancer Epidemiol Biomarkers Prev (2016) 0.77
Feasibility and effectiveness of a community-based smoking cessation intervention in a racially diverse, urban smoker cohort. Am J Public Health (2014) 0.77
Age- and Sex-Specific Trends in Lung Cancer Mortality over 62 Years in a Nation with a Low Effort in Cancer Prevention. Int J Environ Res Public Health (2016) 0.77
Change rates and prevalence of a dichotomous variable: simulations and applications. PLoS One (2015) 0.77
Agmatine protects rat liver from nicotine-induced hepatic damage via antioxidative, antiapoptotic, and antifibrotic pathways. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.77
Moderators of smoking cessation outcomes in a randomized-controlled trial of varenicline versus placebo. Psychopharmacology (Berl) (2017) 0.77
Perspectives of African Americans on lung cancer: a qualitative analysis. Oncologist (2015) 0.76
Targeting Persons With or At High Risk for Chronic Obstructive Pulmonary Disease by State-based Surveillance. COPD (2015) 0.76
Sex differences in resting state brain function of cigarette smokers and links to nicotine dependence. Exp Clin Psychopharmacol (2015) 0.76
How smoking affects the proportion of deaths attributable to obesity: assessing the role of relative risks and weight distributions. BMJ Open (2016) 0.76
Sequence context modulation of polycyclic aromatic hydrocarbon-induced mutagenesis. Environ Mol Mutagen (2013) 0.76
A behavioral smoking treatment based on perceived risks of quitting: A preliminary feasibility and acceptability study with female smokers. Addict Res Theory (2015) 0.76
Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J (2015) 0.76
Smoking: additional burden on aging and death. Genes Environ (2016) 0.76
Gender differences in age of smoking initiation and its association with health. Addict Res Theory (2015) 0.76
Protocol for a human in vivo model of acute cigarette smoke inhalation challenge in smokers with COPD: monitoring the nasal and systemic immune response using a network biology approach. BMJ Open (2015) 0.75
Mortality and Burden of Disease Attributable to Cigarette Smoking in Qingdao, China. Int J Environ Res Public Health (2016) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ (2004) 24.88
Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ (1994) 23.80
The mortality of doctors in relation to their smoking habits; a preliminary report. Br Med J (1954) 18.11
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
The relationship between human smoking habits and death rates: a follow-up study of 187,766 men. J Am Med Assoc (1954) 10.01
Smoking in relation to the death rates of one million men and women. Natl Cancer Inst Monogr (1966) 9.66
The Women's Health Initiative recruitment methods and results. Ann Epidemiol (2003) 8.42
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77
Implementation of the Women's Health Initiative study design. Ann Epidemiol (2003) 7.30
The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet (2012) 7.28
Chronic obstructive pulmonary disease surveillance--United States, 1971-2000. MMWR Surveill Summ (2002) 7.07
Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst (1997) 5.72
The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics. Cancer (2002) 4.88
Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health (1995) 4.60
Smoking and death rates: report on forty-four months of follow-up of 187,783 men. 2. Death rates by cause. J Am Med Assoc (1958) 3.44
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Selection, follow-up, and analysis in the American Cancer Society prospective studies. Natl Cancer Inst Monogr (1985) 2.10
Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene (2002) 2.05
Sociodemographic and geographic variability in smoking in the U.S.: a multilevel analysis of the 2006-2007 Current Population Survey, Tobacco Use Supplement. Soc Sci Med (2011) 1.51
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet (2006) 9.85
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Physical activity and survival after breast cancer diagnosis. JAMA (2005) 8.60
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96
Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet (2007) 6.72
Diabetes and cancer: a consensus report. Diabetes Care (2010) 6.71
Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet (2005) 6.63
Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol (2005) 6.52
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA (2006) 5.75
Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70
Civil registration systems and vital statistics: successes and missed opportunities. Lancet (2007) 5.67
Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol (2009) 5.59
Smoking and mortality--beyond established causes. N Engl J Med (2015) 5.54
Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst (2005) 5.52
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87
ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst (2009) 4.72
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA (2002) 4.39
Monitoring global health: time for new solutions. BMJ (2004) 4.39
Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med (2007) 4.35
Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2005) 4.24
Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Diabetes and cancer: a consensus report. CA Cancer J Clin (2010) 3.95
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Genet (2010) 3.91
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis. Lancet (2010) 3.89
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma. J Natl Cancer Inst (2012) 3.69
An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure. Environ Health Perspect (2014) 3.69
Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68
Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64
Validity of verbal autopsy procedures for determining cause of death in Tanzania. Trop Med Int Health (2006) 3.62
Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int J Epidemiol (2008) 3.61
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Role of smoking in global and regional cardiovascular mortality. Circulation (2005) 3.57
Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int J Cancer (2005) 3.53
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Adult mortality: time for a reappraisal. Int J Epidemiol (2004) 3.41
Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environ Health Perspect (2011) 3.36
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
Mortality registration and surveillance in China: History, current situation and challenges. Popul Health Metr (2005) 3.31
Sample registration of vital events with verbal autopsy: a renewed commitment to measuring and monitoring vital statistics. Bull World Health Organ (2005) 3.30
The way forward. Lancet (2007) 3.28
Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer (2002) 3.26
Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol (2005) 3.25
A road map for efficient and reliable human genome epidemiology. Nat Genet (2006) 3.21
Population Health Metrics Research Consortium gold standard verbal autopsy validation study: design, implementation, and development of analysis datasets. Popul Health Metr (2011) 3.21
Lung cancer incidence in never smokers. J Clin Oncol (2007) 3.20
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol (2008) 3.17
Modeling causes of death: an integrated approach using CODEm. Popul Health Metr (2012) 3.12
Robust metrics for assessing the performance of different verbal autopsy cause assignment methods in validation studies. Popul Health Metr (2011) 3.10
Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study. Obstet Gynecol (2013) 3.08
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Stages of the cigarette epidemic on entering its second century. Tob Control (2012) 2.98
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat Genet (2010) 2.96
Mortality in the Islamic Republic of Iran, 1964-2004. Bull World Health Organ (2007) 2.93